TREVISAN, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 3.819
EU - Europa 1.741
AS - Asia 621
SA - Sud America 13
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 3
Totale 6.208
Nazione #
US - Stati Uniti d'America 3.768
IE - Irlanda 487
IT - Italia 405
HK - Hong Kong 356
SE - Svezia 327
DE - Germania 280
CN - Cina 150
GB - Regno Unito 77
CA - Canada 50
UA - Ucraina 40
IN - India 38
VN - Vietnam 28
DK - Danimarca 26
BE - Belgio 20
FI - Finlandia 18
NL - Olanda 16
TR - Turchia 10
BR - Brasile 9
FR - Francia 7
PH - Filippine 6
PL - Polonia 6
AU - Australia 5
IR - Iran 5
KR - Corea 5
SA - Arabia Saudita 5
SG - Singapore 5
ES - Italia 4
HR - Croazia 4
NO - Norvegia 4
RU - Federazione Russa 4
EG - Egitto 3
EU - Europa 3
GR - Grecia 3
MY - Malesia 3
RS - Serbia 3
TH - Thailandia 3
BG - Bulgaria 2
EE - Estonia 2
IL - Israele 2
JP - Giappone 2
LT - Lituania 2
NZ - Nuova Zelanda 2
PE - Perù 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
CH - Svizzera 1
CL - Cile 1
CZ - Repubblica Ceca 1
HN - Honduras 1
HU - Ungheria 1
KW - Kuwait 1
MN - Mongolia 1
NP - Nepal 1
RO - Romania 1
Totale 6.208
Città #
Ann Arbor 669
Dublin 474
Chandler 403
Fairfield 387
Hong Kong 355
Ashburn 267
Frankfurt am Main 248
New York 238
Princeton 223
Houston 179
Woodbridge 175
Wilmington 168
Seattle 148
Cambridge 119
Lawrence 107
Altamura 99
Milan 69
San Diego 44
Toronto 40
Jacksonville 37
Beijing 28
Shanghai 28
Andover 24
London 22
Brussels 19
Dearborn 19
Boardman 18
Nanjing 18
Chicago 15
Rome 15
Falls Church 13
Guangzhou 12
Helsinki 11
Bergamo 10
Los Angeles 10
Pune 10
Washington 10
Fuzhou 9
Dong Ket 8
Florence 8
Hangzhou 8
Norwalk 7
Redmond 7
Shenzhen 7
São Paulo 7
Groningen 6
Kilburn 6
San Mateo 6
Villafranca Padovana 6
Bologna 5
Mumbai 5
Riyadh 5
Wuhan 5
Belvedere Spinello 4
Chennai 4
Deyang 4
Fremont 4
Hebei 4
Islington 4
Lachine 4
Perugia 4
Poznan 4
Turin 4
Verano Brianza 4
Zagreb 4
Bangalore 3
Bari 3
Bivongi 3
Brescia 3
Cairo 3
Cernusco Sul Naviglio 3
Changsha 3
Dongjak-gu 3
Edmonton 3
Esslingen am Neckar 3
Ferrara 3
Glasgow 3
Gunzenhausen 3
Hounslow 3
Jinan 3
Kocaeli 3
Lappeenranta 3
Leicester 3
Montello 3
Naples 3
Oslo 3
Patna 3
Santa Clara 3
Stockholm 3
Tianjin 3
Upper Marlboro 3
Atlanta 2
Bacu Abis 2
Bengaluru 2
Berlin 2
Cascina 2
Catania 2
Cedar Knolls 2
Chiari 2
Chiswick 2
Totale 4.980
Nome #
Type 2 diabetes mellitus is associated with faster degeneration of bioprosthetic valve: results from a propensity score-matched Italian multicenter study. 233
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial 204
Effects of Manidipine and Delapril in Hypertensive Patients With Type 2 Diabetes Mellitus: The Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND) Randomized Clinical Trial 169
Effects of a low glycemic index high in fiber diet on blood glucose in women with gestational diabetes 140
Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study 134
Strategy to identify subjects with diabetes mellitus more suitable for selective echocardiographic screening: The DAVID-Berg study 133
Switching from Suspend-Before-Low Insulin Pump Technology to a Hybrid Closed-Loop System Improves Glucose Control and Reduces Glucose Variability: A Retrospective Observational Case-Control Study 122
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 106
Pre-gestational diabetes during the COVID-19 pandemic in Bergamo, Italy 106
Genitourinary infections in diabetic patients in the new era of diabetes therapy with sodium-glucose cotransporter-2 inhibitors 105
Influence of dietary fat and carbohydrates proportions on plasma lipids, glucose control and low-grade inflammation in patients with type 2 diabetes—The TOSCA.IT Study 104
Association between On-Treatment Haemoglobin A1c and All-Cause Mortality in Individuals with Type 2 Diabetes: Importance of Personalized Goals and Type of Anti-Hyperglycaemic Treatment 104
Continuous subcutaneous insulin infusion reduces maternal and neonatal risk in pregnant women with type 1 diabetes: An observational cohort study of 122 pregnancies 99
Continuous subcutaneous insulin infusion in Italy: Third national survey 95
Subcutaneous insulin infusion (CSII) in italy: The third national survey [La terapia insulinica sottocutanea continua (CSII) in Italia. Terza indagine nazionale] 93
Antecedent use of renin-angiotensin system inhibitors is associated with reduced mortality in elderly hypertensive Covid-19 patients 91
Liver fibrosis assessed by transient elastography is independently associated with albuminuria in the general United States population 90
Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trial 89
Haemoglobin A1c variability is a strong, independent predictor of all-cause mortality in patients with type 2 diabetes 87
Renal hyperfiltration is independently associated with increased all-cause mortality in individuals with type 2 diabetes: A prospective cohort study 85
Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicentre study 82
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial 79
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study 78
Sodium-glucose transporter 2 inhibitors for renal and cardiovascular protection in US adults with type 2 diabetes: impact of the 2020 KDIGO clinical practice guidelines 78
Association between inhibitors of the renin-angiotensin system and lung function in elderly patients recovered from severe COVID-19 78
Gestione multidisciplinare del paziente con sindrome coronarica acuta e diabete mellito: Dalla terapia antitrombotica al trattamento dell'iperglicemia 73
Elevated risk of death and major cardiovascular events in subjects with newly diagnosed diabetes: Findings from an administrative database 73
La malattia renale e le sue complicanze: percorso per una diagnosi precoce e gestione multidisciplinare 72
Enhanced effects of insulin and angiotensin II on intracellular pH and free cytosolic calcium in fibroblasts from microalbuminuric patients with non-insulin-dependent diabetes mellitus 72
Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study 72
Blood pressure and metabolic effects of acetyl-L-carnitine in type 2 diabetes: DIABASI randomized controlled trial 69
Polyphenol intake and cardiovascular risk factors in a population with type 2 diabetes: The TOSCA.IT study 68
Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial 67
Defining the contribution of chronic kidney disease to all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study 66
Preventing microalbuminuria with benazepril, valsartan, and benazepril-valsartan combination therapy in diabetic patients with high-normal albuminuria: A prospective, randomized, open-label, blinded endpoint (PROBE) study 66
Impact of substitution among generic drugs on persistence and adherence: A retrospective claims data study from 2 Local Healthcare Units in the Lombardy Region of Italy 62
Hypertriglyceridemia Is Independently Associated with Renal, but Not Retinal Complications in Subjects with Type 2 Diabetes: A Cross-Sectional Analysis of the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study 62
Effect of Denosumab on Glucose Homeostasis in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors: A Pilot Study 62
Reply to "Liver fibrosis assessed by transient elastography and albuminuria" 62
Glycated haemoglobin does not accurately predict average capillary glucose in non insulin-treated type 2 diabetes: The PRISMA study experience 56
Independent correlates of urinary albumin excretion within the normoalbuminuric range in patients with type 2 diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study 56
Efficacy of pasireotide in controlling severe hypercortisolism until cardiac transplantation 55
"Insulin autoimmune syndrome": Two very different cases [“Insulin autoimmune syndrome”: Due casi molto diversi] 55
The Hyperfiltering Kidney in Diabetes 55
Metabolic Syndrome, and Not Obesity, Is Associated with Chronic Kidney Disease 55
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial 50
Efficacy of self-monitoring blood glucose as a key component of a chronic care model versus usual care in type 2 diabetes patients treated with oral agents: results of a randomized trial 50
Sitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with type 2 diabetes and covid-19: A multicenter case-control retrospective observational study 49
The Role of Vildagliptin in the Therapy of Type 2 Diabetic Patients with Renal Dysfunction 47
Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial 47
Impact of a complement factor H gene variant on renal dysfunction, cardiovascular events and response to ACE inhibitor therapy in type 2 diabetes 47
Effect of low-dose ramipril on microalbuminuria in normotensive or mild hypertensive non-insulin-dependent diabetic patients. North-East Italy Microalbuminuria Study Group 47
Atrial natriuretic factor in hypertensive and normotensive insulin-dependent diabetics 46
Lipids and renal disease 46
Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trial 46
Effect of insulin and angiotensin II on cell calcium in human skin fibroblasts 45
Effect of Trandolapril on Regression of Retinopathy in Hypertensive Patients with Type 2 Diabetes: A Prespecified Analysis of the Benedict Trial 44
Ronal and metabolic effects of insulin lispro in type 2 diabetic sublects with overt nephropathy 44
Diabetes and work: The need of a close collaboration between diabetologist and occupational physician 43
Modulatory effect of insulin on release of calcium from human fibroblasts by angiotensin II 43
Effects of verapamil added-on trandolapril therapy in hypertensive type 2 diabetes patients with microalbuminuria: the BENEDICT-B randomized trial 43
Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial 42
COMBINED "EN BLOC" LIVER-PANCREAS TRANSPLANTATION USING WHOLE SIZE AND SPLIT LIVER GRAFTS 42
Sodium-hydrogen antiporter: Its possible role in the genesis of diabetic nephropathy 41
Diabetes mellitus in critical jobs [Diabete mellito in attività lavorative critiche] 40
Design and baseline characteristics of the finerenone in reducing cardiovascular mortality and morbidity in diabetic kidney disease trial 40
Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs NPH basal insulin in subjects with Type 1 diabetes 40
Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria 40
In situ Protein Kinase C activity is increased in cultured fibroblasts from Type 1 diabetic patients with nephropathy 39
Treatment of diabetes in patients with kidney disease 39
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial 39
PC-1 amino acid variant Q121 is associated with a lower glomerular filtration rate in type 2 diabetic patients with abnormal albumin excretion rates 39
Cost-effectiveness of two screening programs for microalbuminuria in type 2 diabetes 38
Cardiovascular complications and drug prescriptions in subjects with and without diabetes in a Northern region of Italy, in 2002 and 2012 38
A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria 37
Dapagliflozin and cardiovascular outcomes in type 2 diabetes 37
The decorin gene 179 allelic variant is associated with a slower progression of renal disease in patients with type 1 diabetes 37
Real-World Insulin Treatment in Pregnant Women with Type 1 Diabetes Using an Advanced Hybrid Closed-Loop System 35
Liver Stiffness, Albuminuria and Chronic Kidney Disease in Patients with NAFLD: A Systematic Review and Meta-Analysis 34
Poor glucose control in the year before admission as a powerful predictor of amputation in hospitalized patients with diabetic foot ulceration 34
Increased prevalence of autoimmune thyroid disease after COVID-19: A single-center, prospective study 33
Beneficial effect of lixisenatide after 76 weeks of treatment in patients with type 2 diabetes mellitus: A meta-analysis from the GetGoal programme 33
Continuous subcutaneous insulin infusion is better than multiple daily insulin injections in reducing glucose variability only in type 1 diabetes with good metabolic control 33
Effect on blood pressure of combined inhibition of endothelin-converting enzyme and neutral endopeptidase with daglutril in patients with type 2 diabetes who have albuminuria: a randomised, crossover, double-blind, placebo-controlled trial 33
Assessment of the association between glycemic variability and diabetes-related complications in type 1 and type 2 diabetes 32
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus 31
Skin fibroblasts as a tool for identifying the risk of nephropathy in the type 1 diabetic population 29
Sex differences in cardiovascular disease and cardiovascular risk estimation in patients with type 1 diabetes 29
Resistant hypertension in patients with type 2 diabetes: clinical correlates and association with complications 28
Retinopathy as an independent predictor of all-cause mortality in individuals with type 2 diabetes 26
Insulin-dependent diabetic sibling pairs are concordant for sodium-hydrogen antiport activity 26
The effect of Mindfulness therapy in acromegaly, a pilot study 25
The Remission Clinic approach to halt the progression of kidney disease 25
Switching to the Minimed™ 780G system achieves clinical targets for CGM in adults with type 1 diabetes regardless of previous insulin strategy and baseline glucose control 23
Preventing microalbuminuria in type 2 diabetes 23
Measurable Urinary Albumin Predicts Cardiovascular Risk among Normoalbuminuric Patients with Type 2 Diabetes 23
Na+/H+ antiport activity and cell growth in cultured skin fibroblasts of IDDM patients with nephropathy 23
Long-term kidney and systemic effects of calorie restriction in overweight or obese type 2 diabetic patients (C.Re.S.O. 2 randomized controlled trial) 23
Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin 22
Effect of SGLT2 inhibitors on stroke and atrial fibrillation in diabetic kidney disease: Results from the CREDENCE trial and meta-analysis 22
Totale 6.072
Categoria #
all - tutte 36.777
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.777


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201938 0 0 0 0 0 0 0 0 0 0 15 23
2019/2020415 25 15 8 10 16 21 21 95 98 51 35 20
2020/20211.525 176 174 157 119 74 85 150 123 110 154 94 109
2021/20221.202 99 85 90 67 23 42 60 58 41 256 73 308
2022/20231.926 217 589 154 104 165 327 5 84 114 45 64 58
2023/20241.571 53 48 63 68 264 416 302 61 252 43 1 0
Totale 6.800